1. COVID-19: New anti-body treatment could offer live saving protection  Sky News
  2. Report: Health Ministry to back full return to schools in low-infection areas  The Times of Israel
  3. Trials begin for new anti-COVID 'cocktail' drug  Arab News
  4. COVID-19: UK volunteer first in the world to trial coronavirus antibody treatment  Sky News
  5. Netanyahu said to oppose potential law to mandate virus vaccine  The Times of Israel
  6. View Full coverage on Google News

Bloomberg - Are you a robot?

PM reportedly not in favor of compelling citizens to be inoculated against coronavirus, but discussions said ongoing as to whether public officials can be required to have shotPM reportedly not in favor of compelling citizens to be inoculated against coronavirus, but discussions said ongoing as to whether public officials can be required to have shot

Netanyahu said to oppose potential law to mandate virus vaccine | The Times of Israel

LONDON: An alternative anti-coronavirus jab aimed at protecting those who cannot receive vaccines will enter major trials this weekend. The drug is made by AstraZeneca, the pharmaceutical company that worked with Oxford University in the UK to develop a general vaccine. The alternative injection was developed using antibodies produced by a single coronavirus patient in the US.LONDON: An alternative anti-coronavirus jab aimed at protecting those who cannot receive vaccines will enter major trials this weekend. The drug is made by AstraZeneca, the pharmaceutical company

Trials begin for new anti-COVID ‘cocktail’ drug | Arab News

ASTRAZENECA has nearly developed a new antibody combination drug that will provide 'good protection for many months against infection' from the deadly coronavirus pathogen.ASTRAZENECA has nearly developed a new antibody combination drug that will provide "good protection for many months against infection" from the deadly coronavirus pathogen.

Coronavirus breakthrough: New AstraZeneca anti-body cocktail boosts cure hopes | World | News | Express.co.uk

AstraZeneca<AZN.L> started late-stage trials on Saturday of an experimental long-acting monoclonal antibody combination drug it hopes could be used as a so-called prophylactic to prevent COVID-19 infection in at-risk people for up to 12 months.AstraZeneca<AZN.L> started late-stage trials on Saturday of an experimental long-acting monoclonal antibody combination drug it hopes could be used as a so-called prophylactic to prevent COVID-19 infection in at-risk people for up to 12 months.

AstraZeneca starts new COVID-19 prevention trials of antibody cocktail | Reuters

A participant in Manchester will be the first in the world to take the pharmaceutical giant's Covid-19 treatment which will be trialled on 1,000 volunteers in the UKA participant in Manchester will be the first in the world to take the pharmaceutical giant's Covid-19 treatment which will be trialled on 1,000 volunteers in the UK

Brits first to trial AstraZeneca's 'antibody cocktail' for weak immune systems - Daily Star

Under the agreement, AstraZeneca vaccines would begin arriving in Israel in first half of 2021 ■ Deal includes largest supply of rations Israel has secured so far***

Israel says agreed with AstraZeneca on COVID vaccine rations for 5 million people - Israel News - Haaretz.com

AstraZeneca's new treatment uses man-made proteins that act like natural human antibodies in the immune system.AstraZeneca's new treatment uses man-made proteins that act like natural human antibodies in the immune system.

COVID-19: UK volunteer first in the world to trial coronavirus antibody treatment | UK News | Sky News

A Manchester participant is set to become the first person in the world to receive an 'antibody cocktail,' as part of a trial that could help prevent Covid-19 for up to a year in certain patients.A Manchester participant is set to become the first person in the world to receive an 'antibody cocktail,' as part of a trial that could help prevent Covid-19 for up to a year in certain patients.

Trials for AstraZeneca's new 'antibody cocktail' treatment will begin in the UK | Daily Mail Online

New antibody combination aims to help people with weakened immune systemsNew antibody combination aims to help people with weakened immune systems

Britain to become first country to trial AstraZeneca coronavirus antibody treatment | The Independent

Treatment developed by AstraZeneca from virus-fighting antibodies found in blood of a patient who survived itTreatment developed by AstraZeneca from virus-fighting antibodies found in blood of a patient who survived it

UK trials antibody cocktail that could halt Covid outbreaks in care homes and on cruise ships

Major global clinical trial of the drug, which will involve 5,000 people, is set to begin in ManchesterMajor global clinical trial of the drug, which will involve 5,000 people, is set to begin in Manchester

Covid vaccines: Thousands of Britons who are 'too weak' for jab could be protected by a new antibody treatment

The UK will be the first country to begin clinical trials of a new coronavirus antibody treatment developed by drugs giant AstraZeneca aimed at people with a weakened immune system who cannot be vaccinated.The UK will be the first country to begin clinical trials of a new coronavirus antibody treatment developed by drugs giant AstraZeneca aimed at people with a weakened immune system who cannot be vaccinated.

UK first to trial AstraZeneca 'antibody cocktail' aimed at non-vaccine patients - LBC

Access Denied

This is the largest amount of vaccines from any one company to be sold to Israel.This is the largest amount of vaccines from any one company to be sold to Israel.

Israel to sign for 10 million doses of AstraZeneca’s coronavirus vaccine - The Jerusalem Post

The treatment, aimed at people with a weakened immune system who cannot be vaccinated could prevent Covid-19 infection for up to 12 months. The clinical trial programme will recruit 5,000 participants The treatment, aimed at people with a weakened immune system who cannot be vaccinated could prevent Covid-19 infection for up to 12 months. The clinical trial programme will recruit 5,000 participants

Trials for AstraZeneca's coronavirus 'antibody cocktail' start in the UK - Mirror Online

India News: MUMBAI: The head of an Indian company contracted to make AstraZeneca Plc's Covid vaccine said it could deliver it to health care workers and elderly I.India News: MUMBAI: The head of an Indian company contracted to make AstraZeneca Plc's Covid vaccine said it could deliver it to health care workers and elderly I.

India could get access to AstraZeneca vaccine by January, says local manufacturer | India News - Times of India

The company is recruiting 5,000 participants globally to evaluate the effectiveness of the combination, called AZD7442, to prevent infection for up to 12 months in people who can’t be given vaccines or don’t respond well to them.The company is recruiting 5,000 participants globally to evaluate the effectiveness of the combination, called AZD7442, to prevent infection for up to 12 months in people who can’t be given vaccines or don’t respond well to them.

UK to buy a million doses of AstraZeneca’s antibody treatment - world news - Hindustan Times

An initial supply is expected to arrive in Israel in the first half of 2021, subject to approval by regulatory authorities in Europe, the United States and Israel, a joint statement from Israel and the drug maker saysAn initial supply is expected to arrive in Israel in the first half of 2021, subject to approval by regulatory authorities in Europe, the United States and Israel, a joint statement from Israel and the drug maker says

The treatment is aimed at those with weakened immune system who cannot be vaccinated.The treatment is aimed at those with weakened immune system who cannot be vaccinated.

Trials for AstraZeneca’s new Covid-19 antibody treatment set to begin in the UK | ITV News